Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

BeOne Medicines Ltd. (ONC) Profit Margins

Over the twelve months to 2026-06-30, BeOne Medicines Ltd. (ONC) had gross margin 88.9%, operating margin 15.1%, net margin 10.7%, free cash flow margin 21.7%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ONCBeOne Medicines Ltd.Follow ONC — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
42.9B
P/E TTM
67.6
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days
LineFY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin—97.9%85.5%83.4%77.1%86.0%79.8%84.5%84.4%87.5%88.9%
Operating margin-10940.2%-41.3%-356.1%-224.2%-536.7%-122.3%-126.4%-49.1%-14.9%8.4%15.1%
Net margin-11141.8%-39.1%-339.9%-221.5%-526.1%-123.9%-141.5%-35.9%-16.9%5.4%10.7%
FCF margin-10562.1%-14.1%-311.8%-196.1%-453.6%-132.8%-128.7%-69.9%-16.6%17.6%21.7%

USD billions · SEC XBRL

BeOne Medicines Ltd. — questions

What is BeOne Medicines Ltd.'s gross margin?
88.9% over the twelve months to 2026-06-30.
What is BeOne Medicines Ltd.'s operating margin?
15.1% over the twelve months to 2026-06-30.
What is BeOne Medicines Ltd.'s net profit margin?
10.7% over the twelve months to 2026-06-30.

Every figure on this page comes from BeOne Medicines Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.